Prevalence of latent Mycobacterium tuberculosis infection in hematopoietic stem cell transplantation comparing tuberculin skin test and interferon-gamma release assay

Página do item simplificado
dc.contributorSistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP
dc.contributor.authorCASTRO-LIMA, Victor A. C.
dc.contributor.authorSANTOS, Ana Paula T.
dc.contributor.authorMUSQUEIRA, Priscila T.
dc.contributor.authorMALUF, Natalya Z.
dc.contributor.authorRAMOS, Jessica F.
dc.contributor.authorMARIANO, Livia
dc.contributor.authorROCHA, Vanderson
dc.contributor.authorCOSTA, Silvia F.
dc.date.accessioned2023-08-16T17:45:34Z
dc.date.available2023-08-16T17:45:34Z
dc.date.issued2023
dc.description.abstractThe aim of this study was to evaluate the prevalence of latent Mycobacterium tuberculosis infection in hematopoietic stem cell transplantation candidates, using tuberculin skin test and QuantiFERON-TB Gold-Plus, in a high-burden tuberculosis country. Adult candidates for hematopoietic stem cell transplantation performed both tests before and those submitted to transplantation were followed up for 12 months. The prevalence of latent Mycobacterium tuberculosis infection was 17.1% and a moderate agreement between QuantiFERON-TB Gold-Plus and tuberculin skin test was observed in this population. Previous tuberculosis exposure was a risk factor for latent Mycobacterium tuberculosis infection. No cases of tuberculosis were diagnosed during follow-up period.eng
dc.description.indexMEDLINE
dc.description.indexPubMed
dc.description.indexWoS
dc.description.indexScopus
dc.identifier.citationEUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, v.42, n.7, p.899-902, 2023
dc.identifier.doi10.1007/s10096-023-04613-w
dc.identifier.eissn1435-4373
dc.identifier.issn0934-9723
dc.identifier.urihttps://observatorio.fm.usp.br/handle/OPI/54574
dc.language.isoeng
dc.publisherSPRINGEReng
dc.relation.ispartofEuropean Journal of Clinical Microbiology & Infectious Diseases
dc.rightsrestrictedAccesseng
dc.rights.holderCopyright SPRINGEReng
dc.subjectHematopoietic stem cell transplantationeng
dc.subjectImmunocompromised hosteng
dc.subjectInterferon-gamma release testseng
dc.subjectTuberculosiseng
dc.subjectTuberculineng
dc.subject.otherrecipientseng
dc.subject.wosInfectious Diseaseseng
dc.subject.wosMicrobiologyeng
dc.titlePrevalence of latent Mycobacterium tuberculosis infection in hematopoietic stem cell transplantation comparing tuberculin skin test and interferon-gamma release assayeng
dc.typearticleeng
dc.type.categoryoriginal articleeng
dc.type.versionpublishedVersioneng
dspace.entity.typePublication
hcfmusp.citation.scopus0
hcfmusp.contributor.author-fmusphcVICTOR AUGUSTO CAMARINHA DE CASTRO LIMA
hcfmusp.contributor.author-fmusphcANA PAULA DE TORRES SANTOS
hcfmusp.contributor.author-fmusphcPRISCILA TAVARES MUSQUEIRA
hcfmusp.contributor.author-fmusphcNATALYA ZAIDAN MALUF
hcfmusp.contributor.author-fmusphcJESSICA FERNANDES RAMOS
hcfmusp.contributor.author-fmusphcLIVIA CAROLINE MARIANO COMPTE
hcfmusp.contributor.author-fmusphcVANDERSON GERALDO ROCHA
hcfmusp.contributor.author-fmusphcSILVIA FIGUEIREDO COSTA
hcfmusp.description.beginpage899
hcfmusp.description.endpage902
hcfmusp.description.issue7
hcfmusp.description.volume42
hcfmusp.origemWOS
hcfmusp.origem.pubmed37126131
hcfmusp.origem.scopus2-s2.0-85156168025
hcfmusp.origem.wosWOS:000979944000001
hcfmusp.publisher.cityNEW YORKeng
hcfmusp.publisher.countryUNITED STATESeng
hcfmusp.relation.referenceAbad CLR, 2018, CLIN TRANSPLANT, V32, DOI 10.1111/ctr.13430eng
hcfmusp.relation.referenceBourlon C, 2020, BIOL BLOOD MARROW TR, V26, P1350, DOI 10.1016/j.bbmt.2020.03.013eng
hcfmusp.relation.referenceCheng MP, 2019, CLIN INFECT DIS, V69, P869, DOI 10.1093/cid/ciz048eng
hcfmusp.relation.referenceCompagno M, 2022, INT J ENV RES PUB HE, V19, DOI 10.3390/ijerph191710693eng
hcfmusp.relation.referenceRodrigues MD, 2021, BONE MARROW TRANSPL, V56, P2241, DOI 10.1038/s41409-021-01329-3eng
hcfmusp.relation.referenceLANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310eng
hcfmusp.relation.referenceLee YM, 2014, J INFECTION, V69, P165, DOI 10.1016/j.jinf.2014.02.019eng
hcfmusp.relation.referenceMoon SM, 2013, TRANSPL INFECT DIS, V15, P104, DOI 10.1111/j.1399-3062.2012.00765.xeng
hcfmusp.relation.referencePark JH, 2020, CLIN INFECT DIS, V71, P1977, DOI 10.1093/cid/ciaa030eng
hcfmusp.relation.referenceQin LL, 2013, ASIAN PAC J CANCER P, V14, P7415, DOI 10.7314/APJCP.2013.14.12.7415eng
hcfmusp.relation.referenceShafeque A, 2020, J CLIN MICROBIOL, V58, DOI 10.1128/JCM.01950-19eng
hcfmusp.relation.referenceTomblyn M, 2009, BIOL BLOOD MARROW TR, V15, P1143, DOI 10.1016/j.bbmt.2009.06.019eng
hcfmusp.relation.referenceWorld Health Organization, 1963, WHO STAND TUB TESTeng
hcfmusp.scopus.lastupdate2024-05-17
relation.isAuthorOfPublicationbfb33524-2b5a-4c2c-b4e7-11fce9a38e90
relation.isAuthorOfPublication427daac2-b71c-4ac4-984f-1531a0c1460f
relation.isAuthorOfPublication70796f4f-fae2-4e93-aab9-e7602cc66a0e
relation.isAuthorOfPublication94862b29-31cf-4b21-9129-33ecef701da1
relation.isAuthorOfPublication6cb18c9a-333b-4e60-bc14-e74db7a074e6
relation.isAuthorOfPublication25dcb66a-c9eb-41b8-b47f-f29f89fad4d9
relation.isAuthorOfPublicationde2f3a4b-2ec5-4412-a066-2afdd291efc7
relation.isAuthorOfPublicationd786dd7f-b93c-49e1-8561-c635a58c378f
relation.isAuthorOfPublication.latestForDiscoverybfb33524-2b5a-4c2c-b4e7-11fce9a38e90
Arquivos
Pacote Original
Agora exibindo 1 - 1 de 1
Nenhuma Miniatura disponível
Nome:
art_CASTRO-LIMA_Prevalence_of_latent_Mycobacterium_tuberculosis_infection_in_hematopoietic_2023.PDF
Tamanho:
542.54 KB
Formato:
Adobe Portable Document Format
Descrição:
publishedVersion (English)
Baixar
Coleções
Artigos e Materiais de Revistas Científicas - FM/MCM
Artigos e Materiais de Revistas Científicas - FM/MIP
Artigos e Materiais de Revistas Científicas - HC/ICHC
Artigos e Materiais de Revistas Científicas - HC/IOT
Artigos e Materiais de Revistas Científicas - LIM/31
Artigos e Materiais de Revistas Científicas - LIM/49
Carregar mais